Lista de obras - Paola Alberti - Dominio Público Uruguay

A review of novel biomarkers and imaging techniques for assessing the severity of chemotherapy-induced peripheral neuropathy

artículo científico publicado en 2020

Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study

artículo científico publicado en 2012

Bortezomib and other proteosome inhibitors-induced peripheral neurotoxicity: From pathogenesis to treatment

artículo científico publicado en 2019

Chemotherapy-Induced Neuropathy

artículo científico publicado en 2011

Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools

scientific article published on 04 January 2010

Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale

artículo científico publicado en 2011

Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?

artículo científico publicado en 2015

Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics

artículo científico publicado en 2011

Chemotherapy-induced peripheral neurotoxicity – outcome measures: the issue

artículo científico publicado en 2016

Chemotherapy-induced peripheral neurotoxicity: A multifaceted, still unsolved issue

artículo científico publicado en 2019

Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer

artículo científico publicado en 2012

Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.

artículo científico publicado en 2014

Distal pain and carpal tunnel syndrome diagnosis among cashiers: a longitudinal study

artículo científico publicado en 2017

Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients

artículo científico publicado en 2013

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.

artículo científico publicado en 2017

Erratum to: Distal pain and carpal tunnel syndrome diagnosis among cashiers: a longitudinal study

artículo científico publicado en 2017

Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes.

artículo científico publicado en 2018

Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis.

artículo científico publicado en 2015

Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models

artículo científico publicado en 2018

Guillain-Barré syndrome related to COVID-19 infection

artículo científico publicado en 2020

High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats

artículo científico publicado en 2018

Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer

artículo científico publicado en 2012

Introduction to the Italian section for young neurologists

scientific article published on 14 June 2019

Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity

scientific article published on 16 October 2019

Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study

artículo científico publicado en 2014

Management of side effects in the personalized medicine era: chemotherapy-induced peripheral neuropathy.

artículo científico publicado en 2014

Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy

artículo científico publicado en 2019

Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy

artículo científico publicado en 2018

Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity

scientific article published on 24 April 2020

Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice

scientific article published on 02 June 2020

Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue

artículo científico publicado en 2013

Neurophysiological examination of dorsal sural nerve

artículo científico publicado en 2012

Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings

scientific article published on 29 June 2019

Neuroprotectant agents against oxaliplatin induced neurotoxicity: lackings, facts and future prospective

artículo científico publicado en 2013

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.

artículo científico publicado en 2018

Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity

artículo científico publicado en 2019

Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity

scientific article published on 08 February 2019

Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery.

artículo científico publicado en 2017

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients

artículo científico publicado en 2012

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

artículo científico publicado en 2013

Platinum-drugs induced peripheral neurotoxicity: clinical course and preclinical evidence

artículo científico publicado en 2019

Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures St

artículo científico publicado en 2018

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).

artículo científico publicado en 2013

Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve.

artículo científico publicado en 2018

Severe, reversible nelarabine-induced neuropathy and myelopathy

artículo científico publicado en 2016

Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain

artículo científico publicado en 2021

Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment

artículo científico publicado en 2019

The Content Validity of a Chemotherapy-Induced Peripheral Neuropathy Patient-Reported Outcome Measure

artículo científico publicado en 2017

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

artículo científico publicado en 2012

Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity

scientific article published on 04 December 2019

Toxic neuropathies: Chemotherapy Induced Peripheral Neurotoxicity

scientific article published on 01 October 2019

Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire.

artículo científico publicado en 2018

Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment

scientific article published on 01 October 2019

Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study

artículo científico publicado en 2013

Lista de obras de Paola Alberti

A review of novel biomarkers and imaging techniques for assessing the severity of chemotherapy-induced peripheral neuropathy

Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study

Bortezomib and other proteosome inhibitors-induced peripheral neurotoxicity: From pathogenesis to treatment

Chemotherapy-Induced Neuropathy

Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools

Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale

Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?

Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics

Chemotherapy-induced peripheral neurotoxicity – outcome measures: the issue

Chemotherapy-induced peripheral neurotoxicity: A multifaceted, still unsolved issue

Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer

Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.

Distal pain and carpal tunnel syndrome diagnosis among cashiers: a longitudinal study

Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.

Erratum to: Distal pain and carpal tunnel syndrome diagnosis among cashiers: a longitudinal study

Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes.

Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis.

Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models

Guillain-Barré syndrome related to COVID-19 infection

High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats

Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer

Introduction to the Italian section for young neurologists

Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity

Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study

Management of side effects in the personalized medicine era: chemotherapy-induced peripheral neuropathy.

Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy

Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy

Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity

Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice

Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue

Neurophysiological examination of dorsal sural nerve

Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings

Neuroprotectant agents against oxaliplatin induced neurotoxicity: lackings, facts and future prospective

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.

Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity

Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity

Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery.

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

Platinum-drugs induced peripheral neurotoxicity: clinical course and preclinical evidence

Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures St

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).

Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve.

Severe, reversible nelarabine-induced neuropathy and myelopathy

Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain

Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment

The Content Validity of a Chemotherapy-Induced Peripheral Neuropathy Patient-Reported Outcome Measure

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity

Toxic neuropathies: Chemotherapy Induced Peripheral Neurotoxicity

Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire.

Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment

Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study